Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Market Access

Set Alert for Market Access

Texas Court Ruling Invalidating ACA Threatens Preexisting Illness Coverage, But It's Not The Final Word, Congress Says

A Texas federal district court judge ruled late on Dec. 14 that all of the Affordable Care Act – including parts mandating coverage of preexisting conditions, the medical device excise tax and reporting by medtech firms of payments made to health-care providers under sunshine provisions – are invalid because the health-care law's individual mandate was struck down by a 2017 tax law. But Congress and legal experts say the ruling will be challenged.

Legal Issues Legislation Regulation

Latest From Market Access

Device Week, Jan. 11, 2019 – A New Plan From NHS In A Period Of UK Uncertainty

On this week's podcast, Ashley Yeo talks about the "Long Term Plan" published by the UK's National Health Service this week, and the implications of Brexit.

Device Week United Kingdom

Lawsuit Seeks Expanded Medicare Reimbursement For CGM

A law firm has filed a class action suit against the US Department of Health and Human Services trying to force broader Medicare reimbursement of continuous glucose monitors. Currently, federal health programs will only cover specific types and uses of the diabetes treatment technology.

Legal Issues Reimbursement

QUOTED. Jan. 9, 2019. Niall Dickson.

The UK's National Health Service issued a long-anticipated plan this week outlining significant structural changes it envisions for the country's health-care system. Niall Dickson, who heads the NHS Confederation, says it is high time for changes in how NHS and industry work together.

Quoted Market Access

NHS' New Plan: 'Long-Termism' Is Also Needed In Adoption And Spread Of Technology In UK

The new "NHS Long Term Plan" is an opportunity for an expansive vision in the UK, but it will fall short in its ambitious aims if it merely defaults to old, failed concepts of annualized, silo-nature NHS budgeting. These have proven to be a persistent and significant barrier to the introduction of innovation, says Peter Ellingworth, chief executive of the Association of British HealthTech Industries (ABHI).

United Kingdom Market Access

ABHI 30: NHS Long-Term Plan Promises Diagnosis And Tech Uptake Boost For Industry And Patients

The over-running NHS England Long-Term Plan, to be released in full on Jan. 7, was a central discussion theme at the ABHI’s Market Conference last fall, an occasion that marked 30 years of the association’s support for industry. Early indications about the plan are that digital, early diagnosis, long-term and mental health care are among the key themes and challenges that will be addressed, and supported by the five-year funding boost announced last year. But is the cash settlement enough, and does the plan push the right buttons?

United Kingdom Policy & Regulation

US Regulatory Roundup, 2018: 5 Core Issues That Help Explain The Year In Medtech Policy

Global harmonization, regulatory innovation, rising safety scrutiny, medtech reimbursement hopes and global trade threats were key underlying concepts for the medtech regulatory and policy environment in 2018. Here's a spotlight on those issues and the top 30 articles from last year.

Regulation United States
See All